| __timestamp | Amneal Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 84615000 | 20140000 |
| Thursday, January 1, 2015 | 109679000 | 37173000 |
| Friday, January 1, 2016 | 118757000 | 48616000 |
| Sunday, January 1, 2017 | 109046000 | 108488000 |
| Monday, January 1, 2018 | 230435000 | 244622000 |
| Tuesday, January 1, 2019 | 289598000 | 287000000 |
| Wednesday, January 1, 2020 | 326727000 | 354000000 |
| Friday, January 1, 2021 | 365504000 | 186000000 |
| Saturday, January 1, 2022 | 399700000 | 151000000 |
| Sunday, January 1, 2023 | 429675000 | 232600000 |
| Monday, January 1, 2024 | 267474000 |
Unveiling the hidden dimensions of data
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial for strategic planning. This analysis compares the Selling, General, and Administrative (SG&A) expenses of Ionis Pharmaceuticals, Inc. and Amneal Pharmaceuticals, Inc. from 2014 to 2023. Over this period, Amneal's SG&A expenses surged by over 400%, peaking in 2023, while Ionis saw a more modest increase of around 100%.
These trends highlight differing strategic priorities and market responses, offering a window into each company's operational focus.
Breaking Down SG&A Expenses: Sanofi vs Amneal Pharmaceuticals, Inc.
Vertex Pharmaceuticals Incorporated and Amneal Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: BioMarin Pharmaceutical Inc. vs Amneal Pharmaceuticals, Inc.
Who Optimizes SG&A Costs Better? Ascendis Pharma A/S or Amneal Pharmaceuticals, Inc.
Ionis Pharmaceuticals, Inc. vs Viking Therapeutics, Inc.: SG&A Expense Trends
SG&A Efficiency Analysis: Comparing Ionis Pharmaceuticals, Inc. and Perrigo Company plc
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs PTC Therapeutics, Inc.
Ionis Pharmaceuticals, Inc. and ImmunityBio, Inc.: SG&A Spending Patterns Compared
Comparing SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Amneal Pharmaceuticals, Inc. vs CymaBay Therapeutics, Inc.
Selling, General, and Administrative Costs: Amneal Pharmaceuticals, Inc. vs Soleno Therapeutics, Inc.
SG&A Efficiency Analysis: Comparing Amneal Pharmaceuticals, Inc. and MiMedx Group, Inc.